Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease: A 2x2 Factorial Randomized Phase II Trial Testing N-Acetyl Cysteine and Dexamethasone

NCT05986318 is registered in ClinicalTrials.gov with David Palma as lead sponsor.

NCT NCT05986318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05986318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease: A 2x2 Factorial Randomized Phase II Trial Testing N-Acetyl Cysteine and Dexamethasone
Lead sponsor
David Palma
Phase
Phase 2
Overall status
Recruiting
Start date
January 7, 2025
Completion date
December 31, 2032
Enrollment
98 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, lung cancer